Cumulative incidence of CHF and log-rank comparison adjusted for competing risk of death
| . | Cumulative incidence . | |||
|---|---|---|---|---|
| 5-year . | 10-year . | 15-year . | P . | |
| Entire cohort | 4.8% | 6.8% | 9.1% | |
| By sex | ||||
| Male | 2.7% | 5.0% | 6.7% | <.01 |
| Female | 7.6% | 9.4% | 12.1% | |
| By sex and diagnosis* | ||||
| Male, nonlymphoma | 3.8% | 5.5% | 8.8% | <.01 |
| Female, nonlymphoma | 6.0% | 6.0% | 6.0% | |
| Male, lymphoma | 2.2% | 4.8% | 6.1% | |
| Female, lymphoma | 8.3% | 10.8% | 14.5% | |
| . | Cumulative incidence . | |||
|---|---|---|---|---|
| 5-year . | 10-year . | 15-year . | P . | |
| Entire cohort | 4.8% | 6.8% | 9.1% | |
| By sex | ||||
| Male | 2.7% | 5.0% | 6.7% | <.01 |
| Female | 7.6% | 9.4% | 12.1% | |
| By sex and diagnosis* | ||||
| Male, nonlymphoma | 3.8% | 5.5% | 8.8% | <.01 |
| Female, nonlymphoma | 6.0% | 6.0% | 6.0% | |
| Male, lymphoma | 2.2% | 4.8% | 6.1% | |
| Female, lymphoma | 8.3% | 10.8% | 14.5% | |
Analyzed as female lymphoma versus other.